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(1999–2004) (N = 7500). Participants ﬁlled in a questionnaire about
abdominal symptoms experienced within the last 12 months. The
deﬁnition used: “Subjects stating that they often experience both
abdominal pain and distension and additionally, either altering stool
consistency or borborygmus”, where often is deﬁned as once a
month or more often (pain) and frequently or almost constantly
(other symptoms). We deﬁned the exposed individuals by dividing
the population into IBS symptom groups according to degree of IBS
deﬁnition fulﬁllment at baseline and/or at the follow-up study
5 years later. The two cohorts were followed until December 2013 in
Danish Central Registries to assess all-cause mortality and develop-
ment of severe GI disorders.
Results: The Results showed that the population could be divided
into symptom groups, where 40% had symptoms but did never fulﬁll
the IBS deﬁnition, 8% had ﬂuctuating IBS and 2% had persisting IBS
over a 5 year period. 50% reported no IBS symptoms at either
baseline or follow-up 5 years later. The preliminary Results showed
that none of the IBS symptom groups were associated with increased
all-cause mortality. Further, none of the IBS symptom groups were
associated with an increased development of severe GI disorders. The
associations were adjusted for age, sex, mental vulnerability and the
study cohort.
Conclusion: This longitudinal study is an example where the exposed
individuals were not only deﬁned as ‘IBS’ or ‘non-IBS’ individuals. The
study supports that IBS symptoms in the general population do not
increase mortality or development of severe GI disorders, which is of
great clinical interest. Further research in prognosis of IBS should take
ﬂuctuation of symptoms into account.
doi:10.1016/j.jpsychores.2015.03.109
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Background: Recent researches exploring the relationship between
impaired glucidic tolerance, hyperglycemia or frank type II diabetes
mellitus and symptoms of anxiety and depression, mostly conducted
on in-patients or highly selected samples and on foreign populations,
have reported conﬂicting results. Nevertheless, these medical and
mental conditions are often comorbid in clinical practice. Chronic
and systemic inﬂammation could represent the trait d\'union
between these conditions. Primary care represents an interesting
setting for exploring this comorbidity, given the high prevalence of
psychiatric symptoms displayed by patients. The aims of this
research was to measure the association between hyperglycemia
and symptoms of anxiety and/or depression in out-patients, and to
ﬁll the lack of studies on comorbidity between depression and
anxiety disorders and medical conditions in Primary Care services.
Method: The present was a cross-sectional study. We evaluated all
consecutive patients undergoing a GP consultation in a Northern
Italy practice. Exclusion criteria: age b40 or N80; use of antidepressants
or antipsychoticsmedication; psychosis (schizophrenia, schizoaffective,
bipolar, organic, or tall as psychotic disorder by DSM IV-TR) or major
depression; pregnancy; previous stroke or heart attack; type I diabetes
mellitus. The psychometric assessment was done by HADS (Hospital
Anxiety and Depression Scale). Blood Glucose measurements (BM) in
the last 6 months were considered in our analysis. Hyperglycemia cut-
off: blood glucose N100 mg/dl. The statistical analysis was performed
using STATA with multiple linear regressions.
Results: 209 subjects were recruited in our study (84 men and
125 women). Of those, 48 (22.9%) were affected by hyperglycemia:
22 were men and 26 women. Hyperglycemia was related to HADS-D
score in the men sample (β= .44, p = .01). No association was
found between hyperglycemia and HADS-A, either in men or in
women.
Conclusion: The presence of hyperglycemia, well-known cardiovas-
cular risk factor, may have a clinical value in predicting the presence
of depressive symptoms, especially in men. Further studies should
examine whether our results are generalizable to other populations
and whether they are applicable to clinical depression. Molecular
researches could focus on clarifying the pathophysiological reasons
for such association, also exploring reasons for sex differences.
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Background: Common mental health problems, such as anxiety and
depression, have been related to the imbalance of the autonomous
nervous system, also involved in blood pressure regulation. Low
blood pressure readings have mainly been regarded as positive,
but recent studies suggest low blood pressure is correlated with
depression. The aim of the present research was to investigate the
relationship between symptoms of anxiety and depression and blood
pressure measures in a primary care sample.
Method: We conducted a cross-sectional study that received the
approval of the local Ethical Committee. All consecutive patients
undergoing a GP consultation in a Northern Italy practice were
evaluated, with the following exclusion criteria: age b40 or N80; use
of antidepressants or antipsychotics medication; psychosis or major
depression; previous stroke or heart attack; type I diabetes mellitus;
obesity related to hereditary conditions; pregnancy. The psycho-
metric assessment was done by HADS (Hospital Anxiety and
Depression Scale). Arterial blood pressure was measured twice
using a stethoscope and a sphygmomanometer at the right upper
arm after 5 min of seated rest; the mean measure was considered.
High Blood Pressure (BP) cut-offs: systolic BP ≥130 mm Hg and/or
diastolic BP ≥ 85 mm Hg, according to IDF 2005 guidelines. The
statistical multiple linear regression analysis was performed using
STATA.
Results: 209 subjects were enrolled in the study (125 women and 89
men). 122 subjects (58.1% of the whole sample) suffered from high
blood pressure, and 98 of them (46.7%) followed an antihypertensive
pharmacological therapy. A statistically signiﬁcant inverse correla-
tion between high diastolic BP and symptoms of depression at the
HADS-D scale (β=− .28, p = .01) was found in the whole sample.
The association was maintained in the male subsample, also after
stratiﬁcation by age, especially in the 40–60 years' group of patients
(β=− .53, p = .04). On the contrary, no signiﬁcant association was
found between anxiety and BP measures.
Conclusion: This study conﬁrms an inverse association between high
diastolic BP and depression at epidemiological level in an out-
patients sample; longitudinal studies are needed in order to examine
temporal occurrence and to explore the pathophysiology and the
molecular mechanism at the basis of this association. Further
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